Live
FierceBiotech‘I wouldn’t call it a blip’: Biotech IPOs here to stay after another record-breaking listingEndpoints NewsEnliven prices $400M offering; Jazz drug Zepzelca fails confirmatory studyEndpoints NewsBiopharma's pay oddities of 2025: Executive perks and eccentricitiesFierceBiotechGuardant Health nabs FDA test approval to find patients for Boehringer’s new cancer drugFierceBiotechIpsen R&D chief on pipeline discipline, partnerships and 2026 milestonesClinical OMICsOrgans-on-a-Chip Offer “Elegant Solution” to Quandary of Animal Models in Drug DesignBioPharma DiveRapport ‘fully prepared’ to launch seizure drug solo, CEO saysPharmaVoiceAstellas taps AI to reshape clinical programs as rising stars emergeFierceBiotechChutes & Ladders—Perrigo CEO ousted over ‘personal conduct’BioWorldHengrui Pharmaceuticals reports new BCL6 degradation inducersBioWorldThryv Therapeutics synthesizes SGK1 inhibitorsBioWorldFortvita and Innovent patent new anti-TROP2/B7-H4 ADCs

Archive

Latest Oldest
Total 13170
Page 656 / 732
Query --